Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6522923

CCNc1ccc(Cl)c(Cl)c1.O=C(O)C(F)(F)F

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.51
NPC1 O15118 4/20 0.48
RAB9A P51151 3/20 0.48
MAPT P10636 3/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
LMNA P02545 2/20 0.48
HTT P42858 2/20 0.48
HSP90AA1 P07900 1/20 0.48
NPY1R P25929 1/20 0.48
NPY2R P49146 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
EPHX1 P07099 2/20 0.46
EPHX2 P34913 2/20 0.46
POLB P06746 1/20 0.44
NR1H4 Q96RI1 1/20 0.44
APEX1 P27695 1/20 0.44
FFAR1 O14842 1/20 0.43
IDO1 P14902 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1799567 0.83 CYP3A4 (0.53) CYP3A4NPC1RAB9AMAPTMEN1
Hydrochloric Acid SCHEMBL3399071 0.81 CYP3A4 (0.52) CYP3A4NPC1RAB9AMAPTMEN1
Trifluoroacetic Acid SCHEMBL27550301 0.76 LMNA (0.50) NPC1RAB9AMAPTLMNAFFAR1
SCHEMBL13623800 0.76 SMN1; SMN2 (0.52) CYP3A4NPC1RAB9AMAPTMEN1
SCHEMBL1798335 0.73 LMNA (0.61) MAPTMEN1KMT2ALMNAHTT
SCHEMBL1847384 0.73 FFAR1 (0.55) CYP3A4NPC1RAB9AMAPTMEN1
Trifluoroacetic Acid SCHEMBL28193528 0.73 KMO (0.50) CYP3A4
SCHEMBL733998 0.73 EPHX1 (0.55) CYP3A4NPC1RAB9AMAPTMEN1
Hydrochloric Acid SCHEMBL27687287 0.72 LMNA (0.60) MAPTMEN1KMT2ALMNAHTT
SCHEMBL28877123 0.72 CYP3A4 (0.60) CYP3A4NPC1RAB9AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110053985-A1 NOVEL PIPERIDINE-4-CARBOXYLIC ACID PHENYL-ALKYL-AMIDE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS NEUROSEARCH A/S (DK) 2011-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053985-A1 NOVEL PIPERIDINE-4-CARBOXYLIC ACID PHENYL-ALKYL-AMIDE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS SLC18A2, SLC6A2, SLC18A3 CYP3A4 510/4885NPC1 260/4885RAB9A 803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.